Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice

BACKGROUND: Renal tubulointerstitial fibrosis is a common feature of the final stage of nearly all cause types of chronic kidney disease. Although classic peroxisome proliferator-activated receptor γ (PPARγ) agonists have a protective effect on diabetic nephropathy, much less is known about their di...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Endocrinol Metab (Seoul)
Main Authors: Bae, Kwi-Hyun, Seo, Jung Beom, Jung, Yun-A, Seo, Hye-Young, Kang, Sun Hee, Jeon, Hui-Jeon, Lee, Jae Man, Lee, Sungwoo, Kim, Jung-Guk, Lee, In-Kyu, Jung, Gwon-Soo, Park, Keun-Gyu
Format: Artigo
Jezik:Inglês
Izdano: Korean Endocrine Society 2017
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5368110/
https://ncbi.nlm.nih.gov/pubmed/28256116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2017.32.1.115
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki